Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Staar Surgical Co's Business Segments
Staar Surgical Co's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Reportable Segments
-
Largest Segment
-
Total Revenue
$ 94
Regions Reported
2
Staar Surgical Co does not report a distinct business-segment axis in its filings - its disaggregated revenue is disclosed by product and service category instead. See the Product & Service breakdown below.
Revenue Share by Region -
- Geographic Distribution Foreign50.7%
- Other Countries20.5%
Revenue by Geographic Region -
| Region | Revenue (Millions) | % of Total |
|---|---|---|
| Geographic Distribution Foreign | $ 47 | 50.7% |
| Other Countries | $ 19 | 20.5% |
Description of Staar Surgical Co
Staar Surgical Co. is a California-based medical technology company that specializes in developing, manufacturing, and marketing implantable lenses to treat cataracts, refractive errors, and presbyopia. The company was founded in 1982 and has since grown to become a global leader in ophthalmic surgical products, with operations in over 75 countries worldwide.
Staar Surgical's flagship product is the Visian implantable Collamer lens (ICL), which is used to correct nearsightedness, farsightedness, and astigmatism. The ICL is a small, flexible lens that is surgically implanted behind the pupil and in front of the natural lens of the eye. The lens is made of a biocompatible material called collamer that does not cause an immune response and has been found to be safe and effective in over 1 million procedures worldwide.
In addition to the ICL, Staar Surgical sells a range of other ophthalmic surgical products, including intraocular lenses (IOLs), phacoemulsification systems, and micro-invasive glaucoma surgery (MIGS) devices. The company also recently launched a new product called Evo Viva, a next-generation ICL that incorporates advanced optic designs to enhance visual quality and reduce glare and halos.
Staar Surgical has a strong track record of innovation and research, with over 75 patents and patent applications in the United States and internationally. The company has also invested heavily in clinical trials to demonstrate the safety and effectiveness of its products, with more than 20 major clinical studies conducted to date.
Overall, Staar Surgical Co. is a leading player in the global ophthalmic surgical market, with a strong focus on developing innovative and effective treatment options for a wide range of vision conditions. The company is committed to improving patient outcomes through advanced technology and clinical research, and is well-positioned for continued growth and success in the years ahead.
Staar Surgical's flagship product is the Visian implantable Collamer lens (ICL), which is used to correct nearsightedness, farsightedness, and astigmatism. The ICL is a small, flexible lens that is surgically implanted behind the pupil and in front of the natural lens of the eye. The lens is made of a biocompatible material called collamer that does not cause an immune response and has been found to be safe and effective in over 1 million procedures worldwide.
In addition to the ICL, Staar Surgical sells a range of other ophthalmic surgical products, including intraocular lenses (IOLs), phacoemulsification systems, and micro-invasive glaucoma surgery (MIGS) devices. The company also recently launched a new product called Evo Viva, a next-generation ICL that incorporates advanced optic designs to enhance visual quality and reduce glare and halos.
Staar Surgical has a strong track record of innovation and research, with over 75 patents and patent applications in the United States and internationally. The company has also invested heavily in clinical trials to demonstrate the safety and effectiveness of its products, with more than 20 major clinical studies conducted to date.
Overall, Staar Surgical Co. is a leading player in the global ophthalmic surgical market, with a strong focus on developing innovative and effective treatment options for a wide range of vision conditions. The company is committed to improving patient outcomes through advanced technology and clinical research, and is well-positioned for continued growth and success in the years ahead.
Staar Surgical Company is recognized as a leader in the medical technology field, particularly in the ophthalmic sector. The company is dedicated to the design, development, manufacture, and marketing of innovative solutions, primarily focusing on intraocular lenses (IOLs), implantable collamer lenses (ICLs), and other surgical products tailored for ophthalmic surgery. Staar Surgical aims to enhance visual outcomes for patients around the globe, addressing various eye conditions, particularly cataracts and refractive errors.
Segments
Staar Surgical operates through three main segments, each tailored to meet specific clinical needs and to advance the field of ophthalmology:
1. Surgical Products:
- This segment emphasizes the innovation and provision of a broad array of IOLs essential for cataract surgery. The surgical products segment comprises several variations of IOLs:
- Aspheric IOLs: Engineered to correct spherical aberrations, these lenses enhance visual clarity, particularly in low-light conditions, benefiting patients substantially by improving contrast sensitivity.
- Toric IOLs: Specifically tailored for patients with astigmatism, these lenses correct both cataracts and astigmatism, enabling improved visual acuity without the added burden of glasses for secondary vision correction.
- Multifocal IOLs: Designed to provide simultaneous vision at multiple distances, these premium lenses cater to the needs of patients wishing to reduce their dependence on reading glasses or contact lenses.
- Extended Depth of Focus (EDOF) IOLs: Offering a continuous range of vision, these lenses facilitate clear vision from far to near, wearing less on the visual system and providing comfort across various activities and tasks.
- Implantable Collamer Lenses (ICLs): Utilized primarily for the treatment of myopia (nearsightedness) and hyperopia (farsightedness), these lenses are designed to remain in the eye permanently or until the patient chooses an alternative, offering significant correction abilities for a wide range of refractive errors.
2. Monofocal IOLs:
- This segment revolves around the production and enhancement of monofocal IOLs, which remain the most common choice in cataract surgery.
- Collamer IOLs: Staar’s flagship monofocal offering, Collamer IOLs are fabricated from a highly flexible and biocompatible material designed to integrate seamlessly with ocular tissues while providing excellent visual outcomes. Patients receiving these lenses will typically still need glasses for either distance or reading vision, but they offer a dependable and effective solution for cataract surgery.
3. End-user Products:
- This segment is committed to supporting ophthalmologists by providing a suite of products and services designed to enhance surgical practice and patient care.
- IOL Calculation Software: This cutting-edge software assists ophthalmologists in accurately calculating the power of the IOL required for each patient, ensuring tailored visual outcomes based on individual eye measurements and corneal characteristics.
- Cataract Surgery Equipment: A comprehensive range of surgical tools and techniques is made available, including phacoemulsification systems—devices that facilitate the safe removal of cataracts—and viscoelastic agents utilized during surgery to maintain the anterior chamber and protect ocular tissues.
- Training and Support Services: Staar Surgical is dedicated to providing thorough training and ongoing support for its products, enabling eye care professionals to integrate advanced IOL technology into their surgical practices effectively and optimizing patient outcomes.
- Patient Education Materials: The company develops informative materials that empower patients by providing them with essential knowledge about their eye conditions, possible treatments, and the benefits and implications of various IOL options, ultimately guiding them to make informed decisions regarding their eye care.
Conclusion
Staar Surgical Company epitomizes innovation in the ophthalmic sector, presenting an expansive portfolio of premium products and services. With a steadfast commitment to enhancing visual health through advanced technology and education for both practitioners and patients, Staar Surgical is positioned as a key player in the ongoing evolution of ophthalmic care, specifically addressing cataracts and refractive errors. Their contributions are integral to improving surgical outcomes and patient satisfaction in eye care worldwide.
Segments
Staar Surgical operates through three main segments, each tailored to meet specific clinical needs and to advance the field of ophthalmology:
1. Surgical Products:
- This segment emphasizes the innovation and provision of a broad array of IOLs essential for cataract surgery. The surgical products segment comprises several variations of IOLs:
- Aspheric IOLs: Engineered to correct spherical aberrations, these lenses enhance visual clarity, particularly in low-light conditions, benefiting patients substantially by improving contrast sensitivity.
- Toric IOLs: Specifically tailored for patients with astigmatism, these lenses correct both cataracts and astigmatism, enabling improved visual acuity without the added burden of glasses for secondary vision correction.
- Multifocal IOLs: Designed to provide simultaneous vision at multiple distances, these premium lenses cater to the needs of patients wishing to reduce their dependence on reading glasses or contact lenses.
- Extended Depth of Focus (EDOF) IOLs: Offering a continuous range of vision, these lenses facilitate clear vision from far to near, wearing less on the visual system and providing comfort across various activities and tasks.
- Implantable Collamer Lenses (ICLs): Utilized primarily for the treatment of myopia (nearsightedness) and hyperopia (farsightedness), these lenses are designed to remain in the eye permanently or until the patient chooses an alternative, offering significant correction abilities for a wide range of refractive errors.
2. Monofocal IOLs:
- This segment revolves around the production and enhancement of monofocal IOLs, which remain the most common choice in cataract surgery.
- Collamer IOLs: Staar’s flagship monofocal offering, Collamer IOLs are fabricated from a highly flexible and biocompatible material designed to integrate seamlessly with ocular tissues while providing excellent visual outcomes. Patients receiving these lenses will typically still need glasses for either distance or reading vision, but they offer a dependable and effective solution for cataract surgery.
3. End-user Products:
- This segment is committed to supporting ophthalmologists by providing a suite of products and services designed to enhance surgical practice and patient care.
- IOL Calculation Software: This cutting-edge software assists ophthalmologists in accurately calculating the power of the IOL required for each patient, ensuring tailored visual outcomes based on individual eye measurements and corneal characteristics.
- Cataract Surgery Equipment: A comprehensive range of surgical tools and techniques is made available, including phacoemulsification systems—devices that facilitate the safe removal of cataracts—and viscoelastic agents utilized during surgery to maintain the anterior chamber and protect ocular tissues.
- Training and Support Services: Staar Surgical is dedicated to providing thorough training and ongoing support for its products, enabling eye care professionals to integrate advanced IOL technology into their surgical practices effectively and optimizing patient outcomes.
- Patient Education Materials: The company develops informative materials that empower patients by providing them with essential knowledge about their eye conditions, possible treatments, and the benefits and implications of various IOL options, ultimately guiding them to make informed decisions regarding their eye care.
Conclusion
Staar Surgical Company epitomizes innovation in the ophthalmic sector, presenting an expansive portfolio of premium products and services. With a steadfast commitment to enhancing visual health through advanced technology and education for both practitioners and patients, Staar Surgical is positioned as a key player in the ongoing evolution of ophthalmic care, specifically addressing cataracts and refractive errors. Their contributions are integral to improving surgical outcomes and patient satisfaction in eye care worldwide.